Acer Therapeutics Inc (ACER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,611 | -22,886 | -16,648 | -10,720 | -4,949 |
| Depreciation Amortization | 15 | 71 | 53 | 35 | 18 |
| Accounts receivable | -10,000 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -1,243 | 1,111 | 353 | -127 | -216 |
| Other Working Capital | 7,041 | 3,081 | 1,331 | 356 | -807 |
| Other Operating Activity | 11,804 | 1,595 | 1,763 | 1,754 | 884 |
| Operating Cash Flow | $3,005 | $-17,027 | $-13,148 | $-8,700 | $-5,070 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5 | -11 | -2 | N/A | N/A |
| Investing Cash Flow | $-5 | $-11 | $-2 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,000 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 3,139 | 10,160 | 6,667 | 1,941 | N/A |
| Other Financing Activity | 0 | 563 | 563 | 563 | 0 |
| Financing Cash Flow | $7,139 | $10,722 | $7,230 | $2,504 | $N/A |
| Beginning Cash Position | 5,762 | 12,078 | 12,078 | 12,078 | 12,078 |
| End Cash Position | 15,900 | 5,762 | 6,157 | 5,881 | 7,007 |
| Net Cash Flow | $10,139 | $-6,316 | $-5,920 | $-6,197 | $-5,070 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,005 | -17,027 | -13,148 | -8,700 | -5,070 |
| Capital Expenditure | -5 | -11 | -2 | N/A | N/A |
| Free Cash Flow | 3,000 | -17,038 | -13,150 | -8,700 | -5,070 |